USPTO serial 86953580
Reviewed by CopyMark Law Group
Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Cynthia Johnson Walden
Cynthia Johnson Walden FISH & RICHARDSON P.C.PO BOX 1022MINNEAPOLIS, MN 55540-1022United States| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Computer software for accessing data related to pharmaceutical, medical and healthcare information that may be downloaded from the Internet through a web operating system or portal interface and computer software for use in data collection, data analysis, data integration and reporting related to pharmaceutical, medical and healthcare information; downloadable computer software in the nature of a mobile application for accessing data related to pharmaceutical, medical and healthcare information that may be downloaded from the Internet through a web operating system or portal interface and computer software for use in data collection, data analysis, data integration and reporting related to pharmaceutical, medical and healthcare information | ACTIVE | Nov 30, 2015 |
| 035 | Business consulting and information services related to the medical, pharmaceutical and healthcare industries | ACTIVE | Nov 30, 2015 |
| 042 | Providing temporary use of on-line non-downloadable software for use in data collection, data analysis, data integration and reporting related to pharmaceutical, medical and healthcare information; Software-as-a-service (SaaS) services featuring computer software that provides web-based access to data related to pharmaceutical, medical and healthcare information through a web operating system or portal interface | ACTIVE | Nov 30, 2015 |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 7, 2024 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Dec 7, 2024 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Dec 7, 2024 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jun 28, 2024 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Jul 3, 2023 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Jul 3, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 26, 2018 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| May 25, 2018 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| May 24, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 24, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 15, 2018 | ALIE | ASSIGNED TO LIE | — |
| May 9, 2018 | ALIE | ASSIGNED TO LIE | — |
| May 3, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 4, 2017 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 4, 2017 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 4, 2017 | CNRT | SU - NON-FINAL ACTION - WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 30, 2017 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Oct 30, 2017 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Oct 17, 2017 | IUAF | USE AMENDMENT FILED | — |
| Oct 17, 2017 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Apr 18, 2017 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Feb 21, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 21, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 1, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 13, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 13, 2017 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 13, 2017 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 13, 2017 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 13, 2017 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 7, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 6, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 6, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 7, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 7, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 7, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 7, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 31, 2016 | MPMK | NOTICE OF PSEUDO MARK E-MAILED | — |
| Mar 30, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 29, 2016 | NWAP | NEW APPLICATION ENTERED | — |